Emerging Therapies and Therapeutic Targets for Composite Liver
Disease: NASH
M. Elizabeth Sobhia,
Sonia Kumari,
Harish Kumar
et al.
Abstract:Background:
Liver diseases continue to destroy the lives of people, one of which is
known as Non-alcoholic Steatohepatitis (NASH) that becomes a serious liver disease all around the
world over the last few years. Non-alcoholic Steatohepatitis (NASH) is a progressive form of Nonalcoholic Fatty Liver Disease (NAFLD) and is characterized by liver steatosis, inflammation, different degrees of fibrosis, and hepatocellular injury. The inflammatory mediators play a vital role in
the transition of Non-alcoholic Fatty … Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.